Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

5:00 PM - 5:05 PM ET

Introductions
Speaker: Patel, Sagar, MD - Emory University, Atlanta, GA
5:00 PM - 5:05 PM ET

Introductions
Speaker: Jegadeesh, Naresh, MD - Cook Radiation Oncology, Chicago, Il
5:00 PM - 6:00 PM ET

Novel Delivery and QA
Speaker: Gao, Hao, PhD - UT Southwestern Medical Center, Dallas, TX
5:00 PM - 6:00 PM ET

Novel Delivery and QA
Speaker: Hao, Yao, PhD - Washington Univ School of Medicine, St. Louis, MO
5:00 PM - 6:00 PM ET

Refining Prostate Cancer Care: Integration, Innovation, and Outcomes
Speaker: Sayan, Mutlay, MD - Brigham and Women's Hospital/Dana-Farber, Boston, MA
5:00 PM - 6:00 PM ET

Refining Prostate Cancer Care: Integration, Innovation, and Outcomes
Speaker: Patel, Sagar, MD - Emory University, Atlanta, GA
5:05 PM - 5:10 PM ET

1078 - Bone Marrow-Sparing Extended-Field Chemoradiation with Dose-Dense Neoadjuvant Chemotherapy for FIGO 2018 Stage IIIC2 Cervical Cancer: Early Outcomes of a Prospective Phase II Study
Speaker: Saini, Surendra, MD, PhD, DPH;DPH, FESTRO - All India Institute of Medical Sciences, New Delhi
5:05 PM - 5:10 PM ET

1091 - Phase III Trial to Compare Weekly and Triweekly Usage of Docetaxel and Cisplatin in Concurrent Chemoradiotherapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer
Speaker: Yang, Dan, MD - Beijing Cancer Hospital, Beijing, Beijing
5:05 PM - 5:10 PM ET

1097 - Comparison of Online Adaptive SBRT to Non-Adaptive SBRT in the Treatment of Abdominal and Pelvic Oligometastasis: A Single-Institution Retrospective Analysis
Speaker: Raclin, Tyler, MD - WashU Medicine, Saint Louis, MO
5:05 PM - 5:10 PM ET

1103 - A Multifunctional BSA-THPC@Tc-99m Nanoplatform for Fluorescence/SPECT Dual-Mode Imaging-Guided Synergistic Sonodynamic and Radiotherapy of Tumors
Speaker: Chen, Liting - Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an
5:05 PM - 5:10 PM ET

1127 - Duration of Androgen Receptor Pathway Inhibitor and ADT with Metastasis Directed Therapy In Oligometastatic Cancer of the Prostate (DIRECT): A Phase 2 Randomized Trial
Speaker: Glicksman, Rachel, MD - University of Toronto, Toronto, ON
5:10 PM - 5:15 PM ET

1079 - Nab-Paclitaxel plus Cisplatin Concurrent with Image Guided Volumetric Modulated Arc Therapy for Locally Advanced Cervical Cancer: Five-Year Follow-Up Results of a Single-Arm, Prospective Study
Speaker: Wei, Shuhua, PhD - Peking University Third Hospital, Beijing, Beijing